OTC Hair Loss Treatments Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL OTC HAIR LOSS TREATMENTS INDUSTRY

2.1 Summary about OTC Hair Loss Treatments Industry

2.2 OTC Hair Loss Treatments Market Trends

2.2.1 OTC Hair Loss Treatments Production & Consumption Trends

2.2.2 OTC Hair Loss Treatments Demand Structure Trends

2.3 OTC Hair Loss Treatments Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Minoxidil

4.2.2 Procapil

4.2.3 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Male

4.3.2 Female

4.3.3 Both

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Minoxidil

5.2.2 Procapil

5.2.3 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Male

5.3.2 Female

5.3.3 Both

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Minoxidil

6.2.2 Procapil

6.2.3 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Male

6.3.2 Female

6.3.3 Both

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Minoxidil

7.2.2 Procapil

7.2.3 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Male

7.3.2 Female

7.3.3 Both

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Minoxidil

8.2.2 Procapil

8.2.3 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Male

8.3.2 Female

8.3.3 Both

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Minoxidil

9.2.2 Procapil

9.2.3 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Male

9.3.2 Female

9.3.3 Both

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Merck

10.1.2 J&J

10.1.3 Taisho Pharma

10.1.4 Costco Wholesale

10.1.5 Wal-Mart

10.1.6 Bayer

10.1.7 Zhejiang Wansheng Pharma

10.1.8 Sichuan Medco Huakang Pharma

10.1.9 Zhendong Anter

10.1.10 DrFormulas

10.1.11 Renata

10.1.12 Dr.R.PFLEGER

10.1.13 DS Healthcare Group

10.2 OTC Hair Loss Treatments Sales Date of Major Players (2017-2020e)

10.2.1 Merck

10.2.2 J&J

10.2.3 Taisho Pharma

10.2.4 Costco Wholesale

10.2.5 Wal-Mart

10.2.6 Bayer

10.2.7 Zhejiang Wansheng Pharma

10.2.8 Sichuan Medco Huakang Pharma

10.2.9 Zhendong Anter

10.2.10 DrFormulas

10.2.11 Renata

10.2.12 Dr.R.PFLEGER

10.2.13 DS Healthcare Group

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table OTC Hair Loss Treatments Product Type Overview

Table OTC Hair Loss Treatments Product Type Market Share List

Table OTC Hair Loss Treatments Product Type of Major Players

Table Brief Introduction of Merck

Table Brief Introduction of J&J

Table Brief Introduction of Taisho Pharma

Table Brief Introduction of Costco Wholesale

Table Brief Introduction of Wal-Mart

Table Brief Introduction of Bayer

Table Brief Introduction of Zhejiang Wansheng Pharma

Table Brief Introduction of Sichuan Medco Huakang Pharma

Table Brief Introduction of Zhendong Anter

Table Brief Introduction of DrFormulas

Table Brief Introduction of Renata

Table Brief Introduction of Dr.R.PFLEGER

Table Brief Introduction of DS Healthcare Group

Table Products & Services of Merck

Table Products & Services of J&J

Table Products & Services of Taisho Pharma

Table Products & Services of Costco Wholesale

Table Products & Services of Wal-Mart

Table Products & Services of Bayer

Table Products & Services of Zhejiang Wansheng Pharma

Table Products & Services of Sichuan Medco Huakang Pharma

Table Products & Services of Zhendong Anter

Table Products & Services of DrFormulas

Table Products & Services of Renata

Table Products & Services of Dr.R.PFLEGER

Table Products & Services of DS Healthcare Group

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global OTC Hair Loss Treatments Market Forecast (Million USD) by Region 2021f-2026f

Table Global OTC Hair Loss Treatments Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global OTC Hair Loss Treatments Market Forecast (Million USD) by Demand 2021f-2026f

Table Global OTC Hair Loss Treatments Market Forecast (Million USD) Share by Demand 2021f-2026f